Financial Comparison: TerrAscend (TRSSF) & The Competition

TerrAscend (OTCMKTS:TRSSFGet Rating) is one of 32 publicly-traded companies in the “Agricultural production – crops” industry, but how does it contrast to its peers? We will compare TerrAscend to related businesses based on the strength of its earnings, valuation, risk, dividends, profitability, institutional ownership and analyst recommendations.

Insider and Institutional Ownership

0.0% of TerrAscend shares are owned by institutional investors. Comparatively, 28.0% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 44.3% of TerrAscend shares are owned by insiders. Comparatively, 22.1% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares TerrAscend and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -143.67% -8.24% -3.88%
TerrAscend Competitors -199.08% -18.48% -11.41%

Analyst Ratings

This is a breakdown of recent ratings for TerrAscend and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 3 5 0 2.63
TerrAscend Competitors 55 137 440 23 2.66

TerrAscend presently has a consensus price target of $3.57, indicating a potential upside of 100.37%. As a group, “Agricultural production – crops” companies have a potential upside of 66.55%. Given TerrAscend’s higher probable upside, analysts clearly believe TerrAscend is more favorable than its peers.

Valuation & Earnings

This table compares TerrAscend and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TerrAscend $210.42 million $3.11 million -1.33
TerrAscend Competitors $1.63 billion $92.12 million 7.21

TerrAscend’s peers have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend peers beat TerrAscend on 7 of the 12 factors compared.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.